Penile Size Enhancement: What the Evidence Says

Understanding "Normal" First

NON-SURGICAL OPTIONS

1. Penile Traction Devices (Extenders)

• Evidence level: Moderate - The best non-surgical option with actual clinical data.
• FDA-cleared devices (e.g., Andro-Penis, RestoreX) used for 4-8 hours/day for 3-6 months show modest length gains of 1-2 cm in some studies.
• Also used as first-line for Peyronie's disease (penile curvature).
• Gains are primarily in flaccid and stretched length; erect length gains are smaller.
• No meaningful girth increase has been demonstrated.

2. Vacuum Erection Devices (VED/Pumps)

• Commonly used for erectile dysfunction rehabilitation.
• May temporarily increase size while in use but no permanent enlargement from pumps alone.
• Overuse can cause bruising, petechiae, and even fibrosis.

3. Jelqing

• A manual stretching/milking exercise with no controlled clinical trial evidence of permanent gain.
• Case reports link aggressive jelqing to bruising, vascular injury, urethral trauma, and worsened erectile function. Not recommended.

4. Supplements and Pills

• No peer-reviewed evidence supports any oral supplement for penile enlargement. None are FDA-approved for this purpose. Many are contaminated or contain undisclosed active ingredients.

MINIMALLY INVASIVE OPTIONS

5. Hyaluronic Acid (HA) Filler Injections

• Best evidence among non-surgical methods for girth.
• Injected into the subcutaneous layer of the penile shaft.
• Clinical studies show average girth increase of 1.5-3 cm in circumference.
• Results last 12-24 months before the filler is reabsorbed - not permanent.
• Presented at the AUA 2024 with a favorable safety profile when done by trained specialists.
• Risks: asymmetry, nodule formation, infection, filler migration, vascular injury if done improperly.
• The ICSM 2024 guidelines recognize HA fillers as an option when performed by qualified specialists.

6. Platelet-Rich Plasma (PRP / "P-Shot")

• Injections of your own concentrated platelets.
• Some proponents claim tissue regeneration, but clinical evidence for size gain is very weak. Primarily used for erectile quality improvement.
• Requires repeat sessions, no permanent effect demonstrated.

SURGICAL OPTIONS

7. Suspensory Ligament Release (Length)

• The suspensory ligament anchors the base of the penis to the pubic bone. Cutting it releases 1-2 cm of internal penile shaft into visible length.
• Average gain: 1-2 cm in flaccid/stretched length.
• Complication: Loss of upward erection angle, penile instability during intercourse. Requires post-op traction therapy to maintain gains.
• The SMSNA position statement (2024) recommends thorough counseling and cautions against overpromising results.

8. Fat Grafting (Lipofilling) - Girth

• Autologous fat is harvested via liposuction and injected around the penile shaft.
• Can increase girth by 1-3 cm but fat reabsorption is unpredictable (30-70% reabsorption rate).
• Multiple sessions often required. Risk of lumps, asymmetry, fat necrosis.

9. Penuma Implant - Girth (FDA-cleared)

• A silicone sleeve implant placed under the penile skin via surgery.
• FDA 510(k) cleared for cosmetic girth enhancement.
• Studies show average girth increase of 2-4 cm.
• Risks: infection, implant removal, scarring, altered sensation.

10. Dermal/Tissue Matrix Grafts - Girth

• Allografts or acellular dermal matrices wrapped around the shaft.
• Permanent option with less reabsorption than fat.
• More complex surgery; evidence base smaller than fat grafting.

11. Tunica Expansion Procedures (TEP) - Combined Length + Girth

• Primarily done alongside penile prosthesis implantation for men with erectile dysfunction.
• Staggered incisions in the tunica albuginea allow expansion.
• A 2024 series reported mean length gain of 2.8 cm and girth gain of 1.6 cm, though this is in a specific ED/Peyronie's population.

What Urological Organizations Say (2024-2026)

• The AUA and SMSNA (2024 position statement, PMID 38654638) emphasize that most men seeking enlargement have normal-sized penises and recommend psychological evaluation before surgery.
• The ICSM 2024 (5th International Consultation on Sexual Medicine, PMID 41344863) recognizes select procedures (HA fillers, ligament release, fat grafting, Penuma) as options for appropriately counseled men, but stresses that complication rates are non-trivial and long-term data are limited.
• The 2024 systematic review in Medicina found that patient satisfaction is highly variable and complications (especially with surgical methods) can reduce quality of life.

Summary Table